Abstract
Head and neck squamous epithelial carcinogenesis is a complex multistep process that entails a progressive acquisition of alterations in diverse vital cellular pathways. The nature of these alterations and the order of their occurrence have remained unresolved. In the past 15 years, the thrust of research in this field has centered on the epithelial genetic and/or epigenetic changes attendant to their development and progression. Little efforts, however, have been expended on changes in structural or host microenvironment and their role in these tumors. Only recently has the latter topic become the focus of attention. This review will address recent advances in both cellular and structural findings in head and neck squamous carcinoma development and progression. Targeting these events for biological and therapeutic approaches is a desirable goal for future effective treatment of patients with this cancer.
Keywords: GSTP1 genotypes, DNA methylation, Epidermal Growth Factor, Angiogenesis, Epithelial-Mesenchymal Transformation, surrogate markers
Current Cancer Drug Targets
Title: Pathobiology of Head and Neck Squamous Tumorigenesis
Volume: 7 Issue: 7
Author(s): Adel K. El-Naggar
Affiliation:
Keywords: GSTP1 genotypes, DNA methylation, Epidermal Growth Factor, Angiogenesis, Epithelial-Mesenchymal Transformation, surrogate markers
Abstract: Head and neck squamous epithelial carcinogenesis is a complex multistep process that entails a progressive acquisition of alterations in diverse vital cellular pathways. The nature of these alterations and the order of their occurrence have remained unresolved. In the past 15 years, the thrust of research in this field has centered on the epithelial genetic and/or epigenetic changes attendant to their development and progression. Little efforts, however, have been expended on changes in structural or host microenvironment and their role in these tumors. Only recently has the latter topic become the focus of attention. This review will address recent advances in both cellular and structural findings in head and neck squamous carcinoma development and progression. Targeting these events for biological and therapeutic approaches is a desirable goal for future effective treatment of patients with this cancer.
Export Options
About this article
Cite this article as:
El-Naggar K. Adel, Pathobiology of Head and Neck Squamous Tumorigenesis, Current Cancer Drug Targets 2007; 7 (7) . https://dx.doi.org/10.2174/156800907782418338
DOI https://dx.doi.org/10.2174/156800907782418338 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Toxicity Burden in Head and Neck Cancer: Past, Present, and Future Strategies
Current Cancer Therapy Reviews Acute Hypersensitivity Reactions to Chemotherapy Agents: An Overview
Inflammation & Allergy - Drug Targets (Discontinued) Resistance to Antiangiogenic: Focus on Mechanisms
Current Angiogenesis (Discontinued) Viral Vectors for Cancer Gene Therapy: Viral Dissemination and Tumor Targeting
Current Gene Therapy Recent Innovations in Antibody-Mediated, Targeted Particulate Nanotechnology and Implications for Advanced Visualisation and Drug Delivery
Current Nanoscience A Comparison of Physicochemical Property Profiles of Marketed Oral Drugs and Orally Bioavailable Anti-Cancer Protein Kinase Inhibitors in Clinical Development
Current Topics in Medicinal Chemistry Repressing the Activity of Protein Kinase CK2 Releases Mitochondria-Mediated Apoptosis in Cancer Cells
Current Drug Targets The Activating Receptors of Natural Killer Cells and Their Inter-Switching Potentials
Current Drug Targets Pharmacological Interventions for the Prevention and Treatment of Kidney Injury Induced by Radiotherapy: Molecular Mechanisms and Clinical Perspectives
Current Molecular Pharmacology Research Advances in the Treatment of Melanoma by Treat Melanoma
Current Topics in Medicinal Chemistry Evolution of the Scientific Literature of Cytochrome P450 from 1977 to 2008
Current Drug Metabolism Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives
Current Drug Targets Salen Mn Complexes are Superoxide Dismutase/Catalase Mimetics that Protect the Mitochondria
Current Inorganic Chemistry (Discontinued) Curcumin Targets Circulating Cancer Stem Cells by Inhibiting Self-Renewal Efficacy in Non-Small Cell Lung Carcinoma
Anti-Cancer Agents in Medicinal Chemistry The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters
Anti-Cancer Agents in Medicinal Chemistry Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Current Genomics Novel Melatonin-chitosan Hydrogels as Suitable Oral Bio-drug Delivery Systems to Fight Oral Mucositis: Synergy of Antioxidants and Bioactives in Action
Current Organic Chemistry Editorial: Head and Neck Cancer: Recent Findings and New Targets
Current Topics in Medicinal Chemistry Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy
Current Pharmaceutical Design